Taiwan defends rush to buy 20 million doses of local vaccines still in clinical trials

Taiwan’s authorities have defended their decision to buy 20 million doses of domestically developed Covid-19 vaccines – that are still in clinical trials and not yet authorised for use – saying the island must address the acute vaccine shortage as it reported a further 351 infections and 15 new deaths amid a worsening outbreak.A spokesman for the Central Epidemic Command Centre revealed on Sunday the government had already signed deals with Taiwan’s Medigen Vaccine Biologics Corp and United…

Share this:

What do you think?

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Leave a Reply

Your email address will not be published. Required fields are marked *

North Korea: Orphans ‘volunteered’ into hard labor

Calls grow in South Korea for Olympics boycott over disputed islets’ inclusion on official torch relay map